Oculus Innovative Sciences Schedules Fiscal First Quarter 2008 Financial Results Release and Conference Call Aug 3, 2007
Oculus Innovative Sciences Announces Results From Anti-Inflammatory Study Using Microcyn(R) Technology Jun 26, 2007
Drug Enhancement Company of America Licenses Oculus' Microcyn(R) Technology for Use in First Responder ''Pen-Like'' Applicator Jun 13, 2007
Oculus Schedules Fiscal Fourth Quarter and Full Year 2007 Financial Results Release and Conference Call Jun 6, 2007
Oculus Initiates Patient Enrollment in Phase II Study of Microcyn(R) Technology for Treatment of Mild Diabetic Foot Infections May 21, 2007
